Kevin C. Tang, Director, 10% Owner at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 244,773 shares at $6.72 ($1.7M) on 2020-01-30, disclosed to the SEC on 2020-02-03.
Open-market purchase of $1.7M LJPC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.72 | 81,475 | $548K | 33.0% |
| 2 | $6.75 | 13,292 | $90K | 5.4% |
| 3 | $6.80 | 75,003 | $510K | 30.8% |
| 4 | $6.80 | 75,003 | $510K | 30.8% |
| Total | $6.77 avg | 244,773 | $1.7M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-01-13 | $34.9M | — | Filing → |